Lipidor AB (FRA:L7R) Debt-to-Asset : 0.00 (As of Jun. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Lipidor AB Debt-to-Asset?

Lipidor AB's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2024 was €0.00 Mil. Lipidor AB's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2024 was €0.00 Mil. Lipidor AB's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Jun. 2024 was €2.15 Mil. Lipidor AB's debt to asset for the quarter that ended in Jun. 2024 was 0.00.

Lipidor AB Debt-to-Asset Historical Data

The historical data trend for Lipidor AB's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lipidor AB Debt-to-Asset Chart

Lipidor AB Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Asset

Get a 7-Day Free Trial

0.19

Lipidor AB Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Debt-to-Asset	Get a 7-Day Free Trial															-	0.16	0.19	0.30	-

Competitive Comparison of Lipidor AB's Debt-to-Asset

For the Drug Manufacturers - General subindustry, Lipidor AB's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lipidor AB's Debt-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Lipidor AB's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Lipidor AB's Debt-to-Asset falls into.

Lipidor AB Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Lipidor AB's Debt-to-Asset for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(0.047	+	0)	/	0.252
	=	0.19

Lipidor AB's Debt-to-Asset for the quarter that ended in Jun. 2024 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(0	+	0)	/	2.15
	=	0.00

Lipidor AB (FRA:L7R) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Lipidor AB Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Lipidor AB's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Lipidor AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lipidor AB (FRA:L7R) » Definitions » Debt-to-Asset

Comparable Companies

Traded in Other Exchanges

LIPI:Sweden

Address

c/o Ekonomistubben AB, Box 55931, Stockholm, SWE, 102 16

Website

https://www.lipidor.se

Lipidor AB is a pharmaceutical development company with a pipeline of drug development projects in the preclinical and clinical phases. The company develops drugs for the treatment of skin diseases such as psoriasis, bacterial skin infections, and atopic dermatitis.

Lipidor AB Headlines

No Headlines